We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultra-Fast Cameras Used To Visualize Molecular Activity

By LabMedica International staff writers
Posted on 23 Dec 2008
Scientists in Munich and Boston have been working with new three-dimensional (3D) imaging systems that use ultra-fast cameras to capture high resolution images of the molecular activity in laboratory mice engineered to develop lung cancer. More...
With additional evaluation, the scientists reported the same approach could be used to study cancer in people.

The research was led by Dr. Vasilis Ntziachristos, director of the Institute for Biological and Medical Imaging at the Helmholtz Center (Munich, Germany), and Dr. Mark Niedre, assistant professor of electrical and computer engineering at Northeastern University (Boston, MA, USA). The technology involved required a sophisticated use of light. According to Dr. Niedre, they solved the problems associated with traditional infrared-imaging technology, resulting is a clearer image of molecular markers of inflammation and other lung disorders.

The inventory of genes and proteins associated with cancer and other diseases is growing rapidly: early in November 2008, for instance, scientists reported sequencing the whole genome of a cancer cell for the first time. Molecular imaging technology puts this data in context by allowing scientists to see biologic molecules in action inside diseased cells and tissues. Now, researchers have devised a molecular imaging technique that uses near-infrared light peer deeper into the body.

Fluorescent-protein tags can be generated to target nearly any biologic protein, be it an enzyme that helps cancer cells advance through surrounding tissue or a marker of arthritic inflammation. However, their use has been limited to shallow tissues in humans or to small animals. The markers are triggered by, and emit near-infrared or infrared light, which scatters in the tissue; the more tissue the light has to penetrate, the blurrier the images become. A new 3D near-infrared imaging system utilizes ultra-fast cameras to capture light that has not scattered. The technology been used to create clearer, higher-resolution images of the molecular workings of lung cancer in mice, and with further development, it might be used to study disease in thicker tissues and in humans.

This progress, according to the scientists, should quickly provide researchers with an inside look at how cancer metastasizes inside an animal. The scientists are now trying to determine the precise molecular mechanism that occurs as cancer spreads from one tumor site to another.

Related Links:
Helmholtz Center
Northeastern University


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Hemodynamic System Monitor
OptoMonitor
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.